| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vir Biotechnology, Inc. | EVP, General Counsel, Corp Sec | Common Stock | 78,210 | $403,563 | $5.16 | 05 Nov 2025 | Direct |
| Vir Biotechnology, Inc. | EVP, General Counsel, Corp Sec | Stock Option (Right to Buy) | 70,000 | $107,100 | $1.53 | 22 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | 05 Nov 2025 | 1 | -$12,307 | 4 | EVP, General Counsel, Corp Sec | 07 Nov 2025, 15:27 |
| VIR | Vir Biotechnology, Inc. | 03 Nov 2025 | 1 | -$8,003 | 4 | EVP and General Counsel | 04 Nov 2025, 19:40 |
| VIR | Vir Biotechnology, Inc. | 26 Feb 2025 | 1 | -$67,402 | 4 | EVP and General Counsel | 27 Feb 2025, 12:39 |
| VIR | Vir Biotechnology, Inc. | 22 Feb 2025 | 3 | -$48,590 | 4 | EVP and General Counsel | 25 Feb 2025, 15:34 |
| VIR | Vir Biotechnology, Inc. | 02 Dec 2024 | 1 | -$625 | 4 | EVP and General Counsel | 04 Dec 2024, 15:35 |
| VIR | Vir Biotechnology, Inc. | 06 Nov 2024 | 1 | -$44,454 | 4 | EVP and General Counsel | 07 Nov 2024, 19:20 |
| VIR | Vir Biotechnology, Inc. | 01 Nov 2024 | 2 | -$32,332 | 4 | EVP and General Counsel | 05 Nov 2024, 17:51 |
| VIR | Vir Biotechnology, Inc. | 01 Oct 2024 | 0 | $0 | 3 | EVP and General Counsel | 02 Oct 2024, 12:07 |